Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment.

Saved in:
Bibliographic Details
Title: Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment.
Authors: Hatamnejad A; Ophthalmology, McMaster University Michael G DeGroote School of Medicine, Hamilton, Ontario, Canada.; Vitreous Retina Macula Specialists of Toronto, Etobicoke, Ontario, Canada.; Octane Imaging Lab, Toronto, Ontario, Canada., Dadak R; Ophthalmology, McMaster University Michael G DeGroote School of Medicine, Hamilton, Ontario, Canada.; Vitreous Retina Macula Specialists of Toronto, Etobicoke, Ontario, Canada.; Octane Imaging Lab, Toronto, Ontario, Canada., Orr S; Vitreous Retina Macula Specialists of Toronto, Etobicoke, Ontario, Canada.; Octane Imaging Lab, Toronto, Ontario, Canada., Wykoff C; Retina Consultants of Texas, Bellaire, Texas, USA.; Blanton Eye Institute, Houston Methodist Hospital & Weill Cornell Medical College, Houston, Texas, USA., Choudhry N; Vitreous Retina Macula Specialists of Toronto, Etobicoke, Ontario, Canada Netan.choudhry@vrmto.com.; Octane Imaging Lab, Toronto, Ontario, Canada.; Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.; Cleveland Clinic Canada, Toronto, Ontario, Canada.
Source: BMJ open ophthalmology [BMJ Open Ophthalmol] 2023 Jun; Vol. 8 (1). Date of Electronic Publication: 2023 Jun 15.
Publication Type: Systematic Review; Meta-Analysis; Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101714806 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2397-3269 (Electronic) Linking ISSN: 23973269 NLM ISO Abbreviation: BMJ Open Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2397-3269
DOI:10.1136/bmjophth-2022-001205